Exosome-based combination therapy shows promise for treatment of metabolically challenging disease MASH

DGIST Department of New Biology Professor Yea Kyungmoo and his research team have developed a next-generation exosome-based drug-delivery technology to effectively treat metabolic dysfunction-associated steatohepatitis (MASH), an incurable metabolic disease, in collaboration with Professor Baek Moon-chang of Kyungpook National University School of Medicine.

Can technology transform health science? The promise of exposomics

Every breath we take, every meal we eat, and every environment we encounter leaves a molecular fingerprint in our bodies—a hidden record of our lifelong exposures. In this week’s edition of the journal Science, leading researchers in the field of exposomics explain how cutting-edge technologies are unlocking this biological archive, ushering in a new era of disease prevention and personalized medicine. The scientists lay out a roadmap to overcome technical and logistical challenges and realize the field’s full potential.